These findings indicate a differential cellular response to statin-induced YAP/TAZ phosphorylation, which may underlie variations in statin sensitivity between mesenchymal and epithelial NSCLC phenotypes. The gene discussed is YAP1; the disease is non-small cell lung carcinoma.